Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INSM | INSMED Inc | Chief Financial Officer | $7.09M | -$12.9M | -64.5% | May 28, 2024 |
SCPH | scPharmaceuticals Inc. | Director | Jun 11, 2024 | |||
XLO | Xilio Therapeutics, Inc. | Director | Jun 14, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|